'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Sangani Hospitals Limited
SANGANI (NSE) · ISIN INE0OVI01010 · Hospital · listed 2023
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹38.49 cr | ₹0.5 cr | ₹44.55 cr |
| 30 Sep 2025 standalone | ₹37.33 cr | ₹0 cr | ₹41.34 cr |
| 31 Mar 2025 standalone | ₹36.09 cr | ₹0 cr | ₹38.66 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 74.09% | 0.00% | 0.00% | 25.91% |
Latest filings
- Annual Report FY2025-26 (New) 4 September 2026 · NSE
- Sangani Hospitals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026. 3 September 2026 · NSE
- Sangani Hospitals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regu 16 June 2026 · NSE
- Sangani Hospitals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. 30 May 2026 · NSE
- Submission of Structural Digital Database Compliance Certificate under SEBI (Prohibition of Insider Trading) Regulations, 2015, for the year ended 31st March, 2026 25 May 2026 · NSE
Other companies in Hospital
- Apollo Hospitals Enterprise Limited
- Narayana Hrudayalaya Ltd.
- Global Health Limited
- Max Healthcare Institute Limited
- Aster DM Quality Care Limited
- Fortis Healthcare Limited
- Krishna Institute of Medical Sciences Limited
- Rainbow Childrens Medicare Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.